Evidence map›Paper›PMID 42151610›Full record

ArticleAesthetic plastic surgery2026

Italian Translation, Cultural Adaptation and Clinical Application of the ACNE-Q: Patient-Reported Outcome Measure in Mild-to-Moderate Facial Acne.

Annalisa Cogliandro, Marco Gratteri, Caterina Dianzani, Giovanni Francesco Marangi, Riccardo De Bernardis, Gaia De Angelis, Roberta Romano, Claudio Conforti, Francesco Gratteri, Paolo Persichetti

Abstract read
PubMed Publisher
In one paragraph

Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Annalisa CogliandroFondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Marco GratteriFondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy. m.gratteri@unicampus.it.ORCID http://orcid.org/0000-0001-7375-1524
Caterina DianzaniFondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Giovanni Francesco MarangiFondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Riccardo De BernardisFondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Gaia De AngelisFondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Roberta RomanoFondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Claudio ConfortiIRCCS Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Dermatological Research Hospital, 00167, Rome, Italy.
Francesco GratteriDepartment of Medicine (DIMED), Dermatology Unit, University of Padua, Padua, Italy.
Paolo PersichettiFondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAcne vulgaris (AV) is one of the most common dermatological conditions, affecting over 85% of adolescents and a wide range of young adults. Beyond its cosmetic impact, acne can cause significant psychological and quality of life (QoL) issues, highlighting the importance of patient-reported outcome measures (PROMs). The primary aim of this study was to translate, culturally adapt, and validate the Italian version of the ACNE-Q questionnaire, a disease-specific PROM for acne. The secondary aim was to evaluate the effectiveness of the ACNE-FREE protocol in patients with mild-to-moderate facial acne, using the validated Italian ACNE-Q.

methodsThis prospective study involved 54 patients with mild-to-moderate facial acne treated with the ACNE-FREE protocol. The Italian translation and validation of ACNE-Q followed a rigorous process of forward translation, back-translation, review and patient interviews. Patients completed the ACNE-Q at baseline (T0), after 3 months (T1), and after 6 months (T2). Outcome changes were analyzed with ANOVA test (Prism software).

resultsThe mean age of participants was 25.04 ± 4.23 years, with 39 females and 11 males. All ACNE-Q scale scores demonstrated significant improvements over time, showing reductions in "Symptoms" and "Appearance-related distress" scores (p<0.05), indicating a decrease in symptoms and psychological impact. The "Facial Skin" scale showed an increase in scores, suggestive of clinical improvement. The data support the efficacy of the ACNE-FREE protocol in improving both clinical outcomes and patient QoL.

conclusionsThe ACNE-Q is a reliable and valid tool for assessing patient-reported outcomes in Italian-speaking populations with acne. The ACNE-FREE treatment protocol yielded significant improvements in skin condition and psychosocial parameters, enhancing overall quality of life. An integrated approach addressing both physical symptoms and psychological well-being is essential for optimal acne management. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Indexed as

Acne VulgarisPatient Reported Outcome MeasuresQuality of LifeAdolescentAdultCohort StudiesFemaleHumansItalyMaleProspective StudiesReproducibility of ResultsSeverity of Illness IndexSurveys and QuestionnairesTranslationsTreatment OutcomeACNE-QAcne vulgarisCultural adaptationDermatological treatmentPROMsQuality of life

Identifiers

PMID42151610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.